CD44 and melanoma: Analysis of proteome changes additionally allows for understatingthe interactions of cellular metabolic pathways and their implicationin in vitro tumor modeling, especially when theirup- or downregulation is associated with other molecular markers.For this purpose, we first examined the CD44, MCAM, and vimentin simultaneousexpression in both of the tested melanomas.